中文 | ENG

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................

第57卷 第6期 2024-11
High mortality rates associated with parainfl uenza virus, not metapneumovirus, infections in lung transplant recipients: A retrospective observation

.........................

第57卷 第6期 2024-11
Predatory clinical surgery journal, rescinding the decision to accept submitted article and unjustifi ed rejection and unprofessional conduct

.........................

第57卷 第6期 2024-11
Sacrifi cial of unilateral vertebral artery for fragment removal following vertebral artery injury by air rif le pellet gunshot: A case report

.........................

第57卷 第6期 2024-11
Evaluation of three-dimensional reconstruction technology in precision hepatectomy for primary liver cancer

.........................

第57卷 第6期 2024-11
Exploring the seasonal variation of anorectal disease: A comprehensive study

.........................

第57卷 第6期 2024-11
Efficacy of the minimal-invasive vacuum-assisted biopsy under direct visualization with ultrasound for impalpable breast lesions in Taiwanese female: A retrospective case-control study

.........................

第57卷 第6期 2024-11
Computed tomography on the 5th postoperative day helps distinguish grade C from grade B pancreatic fi stula after pancreaticoduodenectomy for periampullary cancer

.........................

第57卷 第6期 2024-11
Pressurized intraperitoneal aerosol chemotherapy (PIPAC): Why it will transform cancer surgery

.........................

第57卷 第5期 2024-9
Evaluating the pros and cons of anonymous commenting on PubPeer

.........................

第57卷 第5期 2024-9
Infected urachal cyst with urethral stricture disease presenting with intraperitoneal perforation of cyst and pyoperitoneum

.........................

第57卷 第5期 2024-9
COVID-19 vaccination and acute cholecystitis: A rare but important clinical problem

.........................

第57卷 第5期 2024-9
Hobnail-shaped primary prostatic urethral calculus due to urethral stricture disease

.........................
登入帳號才能閱讀全文
 
篇名 Effect of 5-Fluorouracil on N-Acetyltransferase Activity in Colon Cancer Tissues
作者 Chi-Fu Hung, Jin-Gung Chung, Kau-Chi Ku, Jen-Liao
卷期/出版年月 32卷6期 (1999/12)
頁次 245-251
摘要 Human epidemiological studies suggest an association between N-acetyltransferase (NAT) and colon cancer. Arylamine N-acetylation capacity of the human colon mucosa, catalyzed by acetyl coenzyme A-dependent N-acetyltransferase, may be an important causative factor in the inititation of colorectal cancer. Human healthy colon mucosa and colon cancerous cytosol (subcellular fraction) from 40 fresh surgical samples were investigated for the effect of 5-fluorouracil (5-FU) on the activity of NAT toward p-aminiobenzoic acid and 2-amniofluorene using an acetyl coenzyme A (AcCoA) recycling assay and high pressure liquid chromatography (HPLC). 5-FU is a cancer chemotherapeutic agent used in the treatment of colon cancerous cytosol is found to be inhibited by 5-FU. Its presence in the assay medium shows an inhibition in PABA-NAT activity about of 23.4% and 50.5% in healthy colon mucosa (p<0.05), 48.3% and 73.8% in cancerous colon tissues (p<0.02) at 1mM and 2mM of 5-FU concentrations respectively; while as AF-NAT activity decreased about 21.2% and 55.1% in healthy colon mucosa (p<0.05), 42.2% and 68.4% in cancerous colon tissues (p<0.02) with 1mM and 2mM of 5-FU concentrations respectively. The results of this study show that NAT activity in colon cancerous tissue cytosol is higher than that in healthy colon mucosa cytosol, and 5-FU can inhibit NAT activity in healthy colon mucosa as well as in colon cancerous tissue cytosol which can be attributed to its anticancer activity of 5-FU.
關鍵詞 arylamin, colon cancer, 5-fluorouracil, N-acetyltransferase.
分類 Original Articles

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw